Osamu Ukimura
Overview
Explore the profile of Osamu Ukimura including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
278
Citations
2815
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyazaki S, Ogura R, Ohashi M, Shimizu T, Taga H, Ueda T, et al.
IJU Case Rep
. 2025 Mar;
8(2):166-169.
PMID: 40034902
Introduction: Although not frequent, the recurrence of seminoma later than 5-10 years after orchiectomy has been reported. We report a case of recurrence of seminoma 48 years after orchiectomy, with...
2.
Tokuda B, Yamada K, Kozawa N, Takahata A, Iwami Y, Ito-Ihara T, et al.
Eur J Radiol
. 2025 Feb;
185:111995.
PMID: 39954447
Purpose: To investigate temporal changes in multiparametric MRI (mpMRI) findings following lesion-targeted focal therapy with microwave tissue coagulation (MTC) for localized prostate cancer (PCa). Methods: This retrospective study included 33...
3.
Ueda T, Hayakawa K, Horiguchi G, Murashita J, Shiraishi T, Fujimoto S, et al.
Prostate
. 2025 Jan;
e24855.
PMID: 39815445
Background: Differences in the effectiveness of second-generation androgen receptor axis-targeted agents (ARATs) in high-risk metastatic hormone-sensitive prostate cancer (mHSPC) remain unclear. This study aimed to identify the factors influencing the...
4.
5.
Inoue Y, Yamada T, Okusa Y, Taga H, Ueda T, Shiraishi T, et al.
IJU Case Rep
. 2025 Jan;
8(1):28-31.
PMID: 39749306
Introduction: Radical cystectomy for patients who previously underwent both radical prostatectomy and prostatic bed radiation is technically challenging. Case Presentation: A 78-year-old man with a history of radical prostatectomy and...
6.
Narukawa T, Yasuda S, Horinaka M, Taniguchi K, Tsujikawa T, Morita M, et al.
Cancers (Basel)
. 2024 Dec;
16(23).
PMID: 39682244
Background: Histone deacetylase (HDAC) inhibitors have been reported to exhibit immunomodulatory activities, including the upregulation of major histocompatibility complex class I (MHC class I). Although the immunoproteasome plays a pivotal...
7.
Tay K, Fong K, Stabile A, Dominguez-Escrig J, Ukimura O, Rodriguez-Sanchez L, et al.
Prostate Cancer Prostatic Dis
. 2024 Oct;
PMID: 39468217
Introduction: Focal Therapy (FT) is a treatment option for the treatment of limited volume clinically significant prostate cancer (csPCa). We aim to systematically review outcomes of established FT modalities to...
8.
Koyama J, Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, et al.
Int J Urol
. 2024 Oct;
32(2):198-202.
PMID: 39467028
Objective: To evaluate comorbidities in Japanese testicular cancer (TC) survivors in a multi-institutional, cross-sectional study. Methods: This study enrolled TC survivors who visited any of the eight high-volume institutions in...
9.
Narita S, Yanagisawa T, Hatakeyama S, Hata K, Fujita K, Ueda T, et al.
Prostate
. 2024 Sep;
85(1):73-81.
PMID: 39344365
Background: To develop and validate a prognostic risk model for high-risk metastatic hormone-sensitive prostate cancer (mHSPC) patients treated with upfront abiraterone acetate (ABI). Methods: This retrospective multicenter study involved 233...
10.
Hinata N, Murakami S, Nakano Y, Hara I, Kondo T, Hamamoto S, et al.
Int J Clin Oncol
. 2024 Aug;
29(10):1548-1556.
PMID: 39110358
Background: This study aimed to compare the efficacy of robot-assisted partial nephrectomy for completely endophytic renal tumors with the reported outcomes of conventional laparoscopic partial nephrectomy and investigate the transition...